Anti-malarial drug | Treatment outcome | Total | Ecological zone |
---|
Forest | Savannah |
---|
AS-AQ | | n = 140 | n = 59 | n = 81 |
ETF | 0 | 0 | 0 |
LCF | 1 | 1 | 0 |
LPF | 2 | 0 | 2 |
ACPR | 122 | 49 | 73 |
NAa
| 15 | 9b
| 6c
|
AL | | n = 170 | n = 124 | n = 46 |
ETF | 0 | 0 | 0 |
LCF | 8 | 8 | 0 |
LPF | 24 | 10 | 14 |
ACPR | 121 | 103 | 18 |
NAa
| 17 | 3d
| 14e
|
-
aNot assessed
-
bOne was withdrawn on day 2 because she was generally weak. Eight were lost to follow-up: four on day 7; two on day 14; and two on day 21
-
cAll lost to follow-up: three on day 3; two on day 7; and one on day 14
-
dOne was withdrawn on day 0 because of excessive vomiting after intake of medicine. One each was lost to follow-up on days 1 and 2
-
eAll lost to follow-up: four on day 7; seven on day 14; and three on day 21